BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 3312444)

  • 61. Arteriosclerosis in normal and von Willebrand pigs: long-term prospective study and aortic transplantation study.
    Fuster V; Fass DN; Kaye MP; Josa M; Zinsmeister AR; Bowie EJ
    Circ Res; 1982 Nov; 51(5):587-93. PubMed ID: 6814782
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pigs with von Willebrand disease may be resistant to experimental infective endocarditis.
    Johnson CM; Bowie EJ
    J Lab Clin Med; 1992 Oct; 120(4):553-8. PubMed ID: 1402331
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Platelet-vessel wall interaction in health and disease.
    Löwenberg EC; Meijers JC; Levi M
    Neth J Med; 2010 Jun; 68(6):242-51. PubMed ID: 20558854
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ultrastructural studies of platelets of von Willebrand and normal swine.
    Lewis JC; Bowie FJ
    Mayo Clin Proc; 1978 Mar; 53(3):179-83. PubMed ID: 304950
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Thrombin regulation of platelet interaction with damaged vessel wall and isolated collagen type I at arterial flow conditions in a porcine model: effects of hirudins, heparin, and calcium chelation.
    Badimon L; Badimon JJ; Lassila R; Heras M; Chesebro JH; Fuster V
    Blood; 1991 Jul; 78(2):423-34. PubMed ID: 2070078
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis.
    Fuster W; Bowie EJ; Lewis JC; Fass DN; Owen CA; Brown AL
    J Clin Invest; 1978 Mar; 61(3):722-30. PubMed ID: 305924
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Platelet deposition on polyethylene. Dependence of second layer platelet attachment on von Willebrand's disease plasma.
    Sheppeck RA; Garrett KO; Bentz ML; Johnson PC
    ASAIO Trans; 1991; 37(3):M260-1. PubMed ID: 1751138
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Platelet von Willebrand factor.
    Gralnick HR; Williams SB; McKeown LP; Magruder L; Hansmann K; Vail M; Parker RI
    Mayo Clin Proc; 1991 Jun; 66(6):634-40. PubMed ID: 2046403
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Glucose-regulated protein 78 and platelet deposition: effect of rosuvastatin.
    Molins B; Peña E; Padro T; Casani L; Mendieta C; Badimon L
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1246-52. PubMed ID: 20360535
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Platelet interaction to prosthetic materials--role of von Willebrand factor in platelet interaction to PTFE.
    Badimon L; Badimon JJ; Turitto VT; Fuster V
    J Biomater Appl; 1990 Jul; 5(1):27-48. PubMed ID: 2384860
    [No Abstract]   [Full Text] [Related]  

  • 71. Role of platelets in atherogenesis: relevance to coronary arterial restenosis after angioplasty.
    Adams PC; Badimon JJ; Badimon L; Chesebro JH; Fuster V
    Cardiovasc Clin; 1987; 18(1):49-71. PubMed ID: 2955894
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Platelet adhesion, release and aggregation in flowing blood: effects of surface properties and platelet function.
    Baumgartner HR; Muggli R; Tschopp TB; Turitto VT
    Thromb Haemost; 1976 Feb; 35(1):124-38. PubMed ID: 989184
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model.
    Badimon L; Badimon JJ; Galvez A; Chesebro JH; Fuster V
    Arteriosclerosis; 1986; 6(3):312-20. PubMed ID: 3707430
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The aspirin tolerance test in von Willebrand's disease.
    Barbui T; Rodeghiero F; Dini E
    Thromb Haemost; 1977 Aug; 38(2):510-3. PubMed ID: 304259
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.
    Nichols TC; Samama CM; Bellinger DA; Roussi J; Reddick RL; Bonneau M; Read MS; Bailliart O; Koch GG; Vaiman M
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2455-9. PubMed ID: 7708664
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Mathematical analysis of mural thrombogenesis. Concentration profiles of platelet-activating agents and effects of viscous shear flow.
    Folie BJ; McIntire LV
    Biophys J; 1989 Dec; 56(6):1121-41. PubMed ID: 2611327
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of Willebrand factor in platelet - blood vessel interaction, including a discussion of resistance to atherosclerosis in pigs with von Willebrand's disease.
    Bowie EJ; Fuster V; Fass DN; Owen CA
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):267-79. PubMed ID: 6117890
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of hemostasis in flowing blood.
    Grabowski EF; Yam K; Gerace M
    Am J Hematol; 2012 May; 87 Suppl 1():S51-5. PubMed ID: 22495911
    [TBL] [Abstract][Full Text] [Related]  

  • 79. alphaIIbbeta3 antagonism vs. antiadhesive treatment to prevent platelet interactions with vascular subendothelium.
    Melis E; Bonnefoy A; Daenens K; Yamamoto H; Vermylen J; Hoylaerts MF
    J Thromb Haemost; 2004 Jun; 2(6):993-1002. PubMed ID: 15140136
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.
    Girolami A; Fabris F; Marco L; Peruffo R
    Acta Haematol; 1976; 56(3):151-9. PubMed ID: 826070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.